TAMPA, FLORIDA / ACCESS Newswire / July 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that its Board of Directors has approved an $8.1 million debt-to-equity conversion.
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX), a growing force in pharmaceutical distribution and healthcare technology, will appear live on YouTube via the Floorstocks channel (@floorstocks) this Tuesday, July 22 at 1:00 PM EST.
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Floorstocks, a financial media platform with over 1.2 million active retail investors, has released an exclusive CEO interview filmed at the Nasdaq MarketSite with Brian Norton, CEO of Wellgistics Health Inc. (NASDAQ: WGRX). The full interview is now available on YouTube and Floorstocks.com, offering investors a front-row look at one of healthcare’s most disruptive emerging growth companies.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (NDCs), and 275+ pharmacies to its national platform.
TAMPA, FL / ACCESS Newswire / June 10, 2025 / Wellgistics Health (NASDAQ:WGRX) ("Wellgistics Health"), a next-generation drug distribution, digital script routing, and hub fulfillment platform, is proud to announce its official membership in OptiSource, LLC, a group purchasing organization that provides innovative business solutions, group purchasing programs, and other efficiency-enhancing and cost-saving services to its members. This strategic move significantly enhances Wellgistics Health's purchasing power, product access, and support for community-based pharmacy partners.
TAMPA, FLORIDA / ACCESS Newswire / May 29, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced its preliminary inclusion in the Russell 2000 and Russell 3000 Indexes, as part of the 2025 Russell US Indexes annual reconstitution. FTSE Russell released the preliminary list of additions and deletions to the Russell 2000 and Russell 3000 Indexes on Friday, May 23, with final inclusion expected to take effect following the close of the U.S. equity market on Friday, June 27, 2025.
TAMPA, FLORIDA / ACCESS Newswire / May 28, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced key additions to its executive leadership team and Board of Directors. These strategic appointments reflect the Company's commitment to executing on its growth strategy, enhancing operational scale, and delivering long-term shareholder value.
TAMPA, FL / ACCESS Newswire / May 12, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX, "Wellgistics Health"), a healthcare infrastructure and pharmaceutical distribution company leveraging proprietary technology, today announced financial results for its first fiscal quarter ended March 31, 2025.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
TAMPA, FLORIDA / ACCESS Newswire / May 8, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner.
TAMPA, FL / ACCESS Newswire / April 30, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced key unaudited operational performance highlights for the first quarter of 2025, signaling continued acceleration across its national platform.
TAMPA, FLORIDA / ACCESS Newswire / April 24, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced a key leadership change to propel Wellgistics Health's strategic growth initiatives forward by appointing Mark DiSiena as its new Chief Financial Officer.
TAMPA, FLORIDA / ACCESS Newswire / April 15, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) (the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced that it has entered into an amendment to the Membership Interest Purchase Agreement with Wellgistics LLC and Wellgistics LLC's former owners to convert a significant cash payment owed by the Company into shares of the Company's common stock at the initial public offering price of $4.50 per share. Specifically, the Company has converted $1.5 million in debt that the Company owed to a seller entity controlled by Brian Norton, its Chief Executive Officer, and that the Company would have needed to pay by June 14, 2025. The $1.5 million in debt was converted into 333,333 shares of the Company's common stock.
